Congressional disclosures
| Office | Representative (NY-27) |
|---|---|
| Disclosed events | 299 |
| Purchases, all years | 141 |
| Sales | 155 |
| Publicly available | Transaction date | Asset | Action | Owner | Reported amount |
|---|---|---|---|---|---|
| 2023-01-20 | 2022-12-12 | AVXL | sale | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | AROC | purchase | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | CHRD | purchase | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | CIVI | sale | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | CMTG | purchase | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | COGT | purchase | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | CTRA | sale | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | CRGY | sale | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | XPRO | sale | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | XOM | sale | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | FHN | purchase | not_indicated | $1,001 - $15,000 |
| 2023-01-20 | 2022-12-12 | GEVO | purchase | not_indicated | $1,001 - $15,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.